These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18283232)

  • 21. [The socio-economics of depression].
    Ansseau M
    Rev Med Liege; 1998 May; 53(5):308-10. PubMed ID: 9689889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
    Bonafede M; Jing Y; Gdovin Bergeson J; Liffmann D; Makenbaeva D; Graham J; Deitelzweig SB
    Hosp Pract (1995); 2011 Aug; 39(3):16-22. PubMed ID: 21881388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year follow-up of a randomized controlled trial of sertraline and cognitive behavior group therapy in depressed primary care patients (MIND study).
    Mergl R; Allgaier AK; Hautzinger M; Coyne JC; Hegerl U; Henkel V
    J Affect Disord; 2018 Apr; 230():15-21. PubMed ID: 29355727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from SADHART, ENRICHD, and other trials.
    Joynt KE; O'Connor CM
    Psychosom Med; 2005; 67 Suppl 1():S63-6. PubMed ID: 15953805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. I-CARE randomized clinical trial integrating depression and acute coronary syndrome care in low-resource hospitals in China: Design and rationale.
    Li S; Blumenthal JA; Shi C; Millican D; Li X; Du X; Patel A; Gao P; Delong E; Maulik PK; Gao R; Yu X; Wu Y
    Am Heart J; 2018 Aug; 202():109-115. PubMed ID: 29933147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.
    Maurizio B; Silvia M; Antonio C
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1083-5. PubMed ID: 17089109
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness analysis of burning mouth syndrome therapy.
    Hens MJ; Alonso-Ferreira V; Villaverde-Hueso A; Abaitua I; Posada de la Paz M
    Community Dent Oral Epidemiol; 2012 Apr; 40(2):185-92. PubMed ID: 22044166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
    Browne G; Steiner M; Roberts J; Gafni A; Byrne C; Dunn E; Bell B; Mills M; Chalklin L; Wallik D; Kraemer J
    J Affect Disord; 2002 Apr; 68(2-3):317-30. PubMed ID: 12063159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
    Weintraub D; Rosenberg PB; Drye LT; Martin BK; Frangakis C; Mintzer JE; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG;
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).
    Hansen BH; Hanash JA; Rasmussen A; Hansen JF; Andersen NL; Nielsen OW; Birket-Smith M
    J Psychosom Res; 2012 Jan; 72(1):11-6. PubMed ID: 22200516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoeconomic issues in the treatment of depression.
    Saklad SR
    Pharmacotherapy; 1995; 15(6 Pt 2):76S-83S. PubMed ID: 8587854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
    Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ
    Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance study for adolescent depression.
    Cheung A; Kusumakar V; Kutcher S; Dubo E; Garland J; Weiss M; Kiss A; Levitt A
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):389-94. PubMed ID: 18759650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.
    Ghushchyan V; Nair KV; Page RL
    Vasc Health Risk Manag; 2015; 11():25-34. PubMed ID: 25565859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource consumption and healthcare costs of acute coronary syndrome: a retrospective observational administrative database analysis.
    Roggeri A; Gnavi R; Dalmasso M; Rusciani R; Giammaria M; Anselmino M; Roggeri DP
    Crit Pathw Cardiol; 2013 Dec; 12(4):204-9. PubMed ID: 24240551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial.
    Taraz M; Khatami MR; Dashti-Khavidaki S; Akhonzadeh S; Noorbala AA; Ghaeli P; Taraz S
    Int Immunopharmacol; 2013 Nov; 17(3):917-23. PubMed ID: 24121064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
    Lamotte M; Annemans L; Evers T; Kubin M
    Pharmacoeconomics; 2006; 24(2):155-69. PubMed ID: 16460136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.
    Pawęska J; Macioch T; Perkowski P; Budaj A; Niewada M
    Kardiol Pol; 2014; 72(9):823-30. PubMed ID: 24846362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.